MISONIX, INC. (NASDAQ:MSON) Files An 8-K Financial Statements and Exhibits
Item 9.01 of its Initial Report, for the purpose of updating the financial statements and pro forma financial information in accordance with Article 11 of Regulation S-X.
Item 9.01. Financial Statements and Exhibits.
(a) Financial Statements of business acquired.
The balance sheet as of June 30, 2019 of Solsys and the related statements of operations, changes in members’ deficit and cash flows for the six month periods ended June 30, 2019 and 2018, together with the related notes thereto and the independent accountant’s review report thereon are filed as Exhibit 99.1 hereto and are incorporated herein by reference.
(b) Pro forma financial information.
The unaudited pro forma condensed consolidated combined statements of operations for the year ended June 30, 2019 and for the three months ended September 30, 2019 is filed as Exhibit 99.2 hereto and are incorporated herein by reference.
(d) Exhibits
| Exhibit No. | Description |
| 23.1 | Consent of PBMares, LLP, independent registered public accounting firm of Solsys Medical, LLC |
| 99.1 | Balance sheet as of June 30, 2019 of Solsys and the related statements of operations, changes in members’ deficit and cash flows for the six month periods ended June 30, 2019 and 2018, together with the related notes thereto and the independent accountant’s review report thereon |
| 99.2 | Unaudited pro forma condensed consolidated combined statements of operations for the year ended June 30, 2019 and for the three months ended September 30, 2019 |
MISONIX INC Exhibit
EX-23.1 2 f8k12b092719a1ex23-1_misonix.htm CONSENT OF PBMARES,…
To view the full exhibit click here
About MISONIX, INC. (NASDAQ:MSON)
MISONIX, INC. (Misonix) is a surgical device company. The Company designs, manufactures and markets therapeutic ultrasonic products across the world for spine surgery, skull-based surgery, neurosurgery, wound and burn debridement, cosmetic surgery, laparoscopic surgery and other surgical applications. The Company’s products include BoneScalpel, BoneScalpel MIS System, SonicOne O.R. System and SonaStar. BoneScalpel is an ultrasonic cutting system with applications in orthopedic and reconstructive surgery, as well as neurosurgery. BoneScalpel MIS System offers deep cuts through osseous structures with minimal blood loss. Misonix SonicOne O.R. System is an ultrasonic surgical debridement system that allows surgeons to address the challenges chronic wounds present to them, the patient, and the health-care system. SonaStar is used for neurosurgical procedures, such as skull/non-skull base tumor resections, transnasal procedures and acoustic mengiomas.
